Johnsen testicular biopsy score. by Halime Tozak Yıldız (21238185)

“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”

Nanoparticle tracking analysis. by Halime Tozak Yıldız (21238185)

“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”

Sperm count and motility. by Halime Tozak Yıldız (21238185)

“…<div><p>Purpose</p><p>Cisplatin is a commonly used chemotherapy agent effective against various cancers, however it induces significant gonadotoxicity and infertility due to its adverse effects on testicular function. …”

S1 Data - by Jan Willem Koten (17743224)

“…The square root of the detectable connectivity r = 0.09 suggests that only 0.81% of the connectivity is explained by working memory-related time course fluctuations. Null hypothesis significance testing (NHST)-based analysis revealed that within-subject time course reliability markedly affects the significance levels at which paths can be detected at the group level. …”

Connectivity statistics. by Jan Willem Koten (17743224)

“…The square root of the detectable connectivity r = 0.09 suggests that only 0.81% of the connectivity is explained by working memory-related time course fluctuations. Null hypothesis significance testing (NHST)-based analysis revealed that within-subject time course reliability markedly affects the significance levels at which paths can be detected at the group level. …”

Quantitative real-time PCR analysis of high-risk CRLs and co-expressed CRGs in GBM human cell lines and the GBM mouse model. by Yajia Chen (20685780)

Subjects:

Expression of high-risk CRLs and co-expression CRGs in the GBM cuproptosis model. by Yajia Chen (20685780)

Subjects:

Analysis of independent prognostic factors. by Yajia Chen (20685780)

Subjects:

Evaluation of risk model. by Yajia Chen (20685780)

Subjects:

Relationship of risk score with immune status. by Yajia Chen (20685780)

Subjects:

Data processing and predictive model construction. by Yajia Chen (20685780)

Subjects:

Drug concentrations for constructing a normal astrocyte cuproptosis model and expression of high-risk CRLs and co-expression CRGs in the human astrocyte cuproptosis model. by Yajia Chen (20685780)

Subjects:

Summary of the program evaluation. by Anton Kurapov (11346019)

“…Participants reported significant pre-post reductions in the severity of symptoms, with sleep problems decreasing by 22.60% (Cohen’s <i>d </i>= 0.53), insomnia by 35.08% (<i>d</i> = 0.69), fear of sleep by 32.43% (<i>d</i> = 0.25), anxiety by 27.72% (<i>d</i> = 0.48), depression by 28.67% (<i>d</i> = 0.52), PTSD by 32.41% (<i>d</i> = 0.51), somatic symptoms by 24.52% (<i>d</i> = 0.51), and perceived stress by 17.90% (<i>d</i> = 0.39). …”

Patient status overview. by Farayi Kaseke (19560197)

“…</p><p>Conclusion</p><p>The study findings demonstrate that hospital bill payment methods, housing status and staying with relatives, educational attainment, functional outcome, and age significantly affect survival outcomes among stroke patients. …”

The result of molecular dynamics simulation. by Ashraf Attia Mahmoud (21262201)

Subjects:

Migration map of the center of gravity of older adults’ health level in the Yangtze River Economic Belt. by Mengmeng Yang (475288)

Subjects:

Extraction of demaging missense mutations from the TCGA Database. by Ashraf Attia Mahmoud (21262201)

Subjects:

Demographic characteristics of study participants. by Patrick Mbullo Owuor (20776036)

Subjects:

Structural alterations in hydrogen bond networks of the TP53 protein caused by mutations G266E (A-B), G105C (C-D), R273C (E-F), R280G (G-H), and Q136P (I-J). by Ashraf Attia Mahmoud (21262201)

Subjects:

(A) The distribution of mutations within the 3D structure of the TP53 protein. by Ashraf Attia Mahmoud (21262201)

Subjects: